Skip to main content
Caplight Logo









AlleSense

AlleSense

Private
MelbourneHealthcare & Life Scienceshttps://allesense.com

Last Round

VC Round

May 28, 2026

Total Funding Raised

$1.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AlleSense operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a VC Round in May 2026.

AlleSense is a diagnostic equipment company that has developed a nanofabricated microscope slide for high-contrast, full-color imaging without the use of chemicals.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AlleSense Comparables

Compare AlleSense with similar companies based on industry and business-model similarity.

AlleSense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xfold Imaging Oy
81%
illumiSonics Inc.
77%
Phi Optics
69%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AlleSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 28, 2026
SeedDec 21, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

AlleSense Investors

Notable investors and investment history

AlleSense investors
InvestorRounds
Welcome VenturesVC Round, Seed
La Trobe Accelerator ProgramSeed
Breakthrough VictoriaVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2026

    $3.6M round led by Welcome Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

AlleSense Filings

Explore SEC and related filing metadata, where available.

AlleSense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AlleSense's valuation, stock price, and market status.

Is AlleSense a public or private company?

AlleSense is a private company.

What is the current stock price of AlleSense?

AlleSense is a private company, so its shares have no public market price. Caplight tracks AlleSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AlleSense worth (valuation)?

Valuation information for AlleSense is not publicly available.

Can I buy AlleSense stock?

AlleSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AlleSense's last funding round?

AlleSense's most recent funding round was VC Round on May 28, 2026.

Who are the main investors in AlleSense?

Key investors in AlleSense include Welcome Ventures.

Will AlleSense IPO soon?

No public IPO plans have been announced for AlleSense.

How can I track AlleSense secondary market activity?

Caplight tracks bids, offers, and trades in AlleSense's shares on secondary markets.

Firmographic Details

HeadquartersMelbourne
Year Founded2023
Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?